0
0 (0%)
Opthea Ltd [CKDXF]
Source:
Company Overview
Opthea Ltd is a clinical-stage biopharmaceutical company developing a novel therapy for the treatment of highly prevalent and progressive retinal diseases.
| Country | United States |
| Headquarters | south yarra |
| Phone Number | 61 3 9826 0399 |
| Industry | manufacturing |
| CEO | Fred Guerard |
| Website | www.opthea.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.1 |
| Operating Profit | $-191.8 |
| Net Income | $-220.2 |
| Net Cash | $82.7 |
Profit Ratios
| Gross Margin | $0.1 |
| Operating Margin | -153,885.4 |
| Profit as % of Revenues | -0.1% |
| Profit as % of Assets | -233.2% |
| Profit as % of Stockholder Equity | 290.5% |
Management Effectiveness
| Return on Equity | 290.5% |
| Return on Assets | -116.7% |
| Turnover Ratio | 0.1% |
| EBITA | $-191.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $188.8 |
| Total Liabilities | $264.6 |
| Operating Cash Flow | $-161 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $243.7 |
